| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 24 |
| 1 | SILDENAFIL CITRATE | 21 |
| 2 | TREPROSTINIL | 21 |
| 3 | MACITENTAN | 19 |
| 4 | SELEXIPAG | 18 |
| 5 | SPIRONOLACTONE | 17 |
| 6 | TADALAFIL | 15 |
| 7 | SILDENAFIL | 14 |
| 8 | ASPIRIN | 12 |
| 9 | ASPIRIN 325 MG | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYCERINE | 1 | 0.0031 |
| 1 | OXYTOCIN | 4 | 0.0013 |
| 2 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | 2 | 0.0012 |
| 3 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 4 | SELEXIPAG | 18 | 0.0007 |
| 5 | IOPAMIDOL | 2 | 0.0007 |
| 6 | FLUNISOLIDE | 1 | 0.0007 |
| 7 | GLUCAGON | 2 | 0.0005 |
| 8 | NITROUS OXIDE | 1 | 0.0005 |
| 9 | TAFAMIDIS MEGLUMINE | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 27 |
| 1 | Loop Diuretic [EPC] | 26 |
| 2 | Prostacycline Vasodilator [EPC] | 25 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 24 |
| 4 | Aldosterone Antagonist [EPC] | 18 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 18 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 7 | Corticosteroid [EPC] | 16 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 12 |
| 9 | Osmotic Laxative [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 4 | 0.0013 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 18 | 0.0007 |
| 2 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 10 | 0.0003 |
| 5 | Vasopressin V2 Receptor Antagonist [EPC] | 4 | 0.0003 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 7 | Prostacycline Vasodilator [EPC] | 25 | 0.0002 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 24 | 0.0002 |
| 9 | Endothelin Receptor Antagonist [EPC] | 27 | 0.0001 |